drugset / Trial / NCT02888444

Smoking Relapse Prevention Among COPD Ex-smokers

NCT02888444

Phase 3 Terminated 8 enrolled University of Auckland, New Zealand
RandomizedParallel-groupTriple-blindPrevention

Summary

A placebo-controlled trial to determine whether recent ex-smokers with COPD who successfully stop smoking after taking varenicline are less likely to relapse back to smoking if they continue using varenicline for a further 12 weeks

Timeline

Start
2017-07-31
Primary completion
2018-04-13
Completion
2018-04-13

Drugs

EvaluationDrugModalityDoseRoute
Comparator Varenicline Small molecule 0.5 mg